Cerium Pharmaceuticals, Inc., 2026-08-06
A new SEC Form D private-offering notice from Gaithersburg, MD, a $2,544,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical stage biopharmaceutical company developing therapies for rare kidney diseases, including a treatment for Primary Membranous Nephropathy.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- EpiWatch, Inc., 2026-08-19, $500K, Baltimore, MD
- InnovoTEX Inc., 2026-08-06, $4M, Austin, TX
- BZAR Technologies, Inc., 2026-08-18, $100K, Ijamsville, MD
- QUICKTAKE HEALTH CO, 2026-08-06, $2.1M, New Orleans, LA
- Georgiamune, Inc., 2026-08-17, $131.9M, Gaithersburg, MD
- HCW Biologics Inc., 2026-08-06, $1.6M, Miramar, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.